How toxic proteins stress nerve cells
The research group led by Dr Mahalakshmi Subramaniam and Prof. Jochen Roeper at the Institute for Neurophysiology at the Goethe University, in collaboration with researchers from Frankfurt’s Experimental Neurology Group…
Phase III trial of Israpidine
Researchers at the University of California, San Diego School of Medicine have launched a Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to…
Alpha Synuclein in the spotlight again
The protein alpha-synuclein is a well-known player in Parkinson’s disease and other related neurological conditions, such as dementia with Lewy bodies. Alpha-synuclein typically resides at presynaptic terminals — the communication…
Crowdfunding for Parkinson’s Research
A Scottish company, Parkure, part of the Edinburgh Science Triangle collaboration, is looking to raise a total of £100,000 from crowdfunding to help find a cure for Parkinson’s, which affects…
Update on Tilo’s Research
Our local research expert, Dr Tilo Kunath, has recently produced an update on the progress of his research at the MRC Centre for Regenerative Medicine, Little France. You can download…
Cinnamon may help to slow down Parkinson’s
Using cinnamon, a common food spice and flavouring material, can reverse the biomechanical, cellular and anatomical changes that occur in the brains of mice with Parkinson’s disease (PD), neurological scientists…
- « Previous Page
- 1
- ...
- 13
- 14
- 15
- 16
- 17
- ...
- 20
- ...
- 23
- Next Page »